Synchem Pharmaceuticals Private Limited, a active private limited company, was established on 19 April 2000 in Indore, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24239MP2000PTC051978. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.13 M.
It upholds a compliant status. Employing 159 professional, Its leadership includes Dinesh Kumar Jain (Whole-Time Director), Manish Jain (Whole-Time Director), Dharmendra Jain (Managing Director). Past directors included Manish Jain. It holds ₹2.14 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 38 Sr Compound, Dewas Naka, Ab Road, Indore, Madhya Pradesh, 452010.
U24239MP2000PTC051978
051978
19 April 2000
₹2.50 M
₹2.13 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Synchem Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Kumar Jain | Whole-Time Director | 19 Apr 2000 | Current |
| Manish Jain | Whole-Time Director | 01 Jun 2007 | Current |
| Dharmendra Jain | Managing Director | 19 Apr 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synchem Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 92.56% increase. The company also saw a substantial improvement in profitability, with a 868.1% increase in profit. The company's net worth Soared by an impressive increase of 66.66%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Synchem Pharmaceuticals had a promoter holding of 99.44% and a public holding of 0.56%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹21,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2021 | Axis Bank Limited | ₹9.00 M | Open |
| 30 Mar 2016 | State Bank Of India | ₹1.00 Cr | Open |
| 22 Apr 2002 | State Bank Of India | ₹2.40 M | Open |
Explore comprehensive loan charge details -
Synchem Pharmaceuticals has a workforce of 159 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Synchem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synchem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Synchem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Synchem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 9.00 M with Charge ID 100458843 was registered on 14 Jun 2021. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 10.00 M with Charge ID 100025756 was registered on 30 Mar 2016. was documented.
Manish Jain was appointed as a Whole-time director was appointed as a Whole-time director on 01 Jun 2007 & has been associated with this company since 18 years 6 months . was recorded as a recent event.
A charge with State Bank Of India of Rs. 2.40 M registered on 22 Apr 2002 with Charge ID 80027923 was modified on 29 Mar 2007. was recorded as a recent event.
The CIN of Synchem Pharmaceuticals Private Limited is U24239MP2000PTC051978.
Synchem Pharmaceuticals Private Limited is headquartered at 38 Sr Compound, Dewas Naka, Ab Road, Indore, Madhya Pradesh, 452010.
Synchem Pharmaceuticals Private Limited was incorporated on 19 April 2000.
The current directors of Synchem Pharmaceuticals Private Limited are
The primary industry of Synchem Pharmaceuticals Private Limited is Manufacturing.
Synchem Pharmaceuticals Private Limited is unlisted.
The authorized capital of Synchem Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.13 M.
The compliance status of Synchem Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX